Advertisement
Concise Publication Free access | 10.1172/JCI106859
1McGill University Clinic, Royal Victoria Hospital, Montreal 112, Quebec, Canada
Find articles by Friesen, H. in: JCI | PubMed | Google Scholar
1McGill University Clinic, Royal Victoria Hospital, Montreal 112, Quebec, Canada
Find articles by Guyda, H. in: JCI | PubMed | Google Scholar
1McGill University Clinic, Royal Victoria Hospital, Montreal 112, Quebec, Canada
Find articles by Hwang, P. in: JCI | PubMed | Google Scholar
1McGill University Clinic, Royal Victoria Hospital, Montreal 112, Quebec, Canada
Find articles by Tyson, J. in: JCI | PubMed | Google Scholar
1McGill University Clinic, Royal Victoria Hospital, Montreal 112, Quebec, Canada
Find articles by Barbeau, A. in: JCI | PubMed | Google Scholar
Published March 1, 1972 - More info
Stimulation and inhibition tests are proposed for evaluating prolactin secretion. Thyrotropin-releasing hormone (TRH) stimulates the release of prolactin from the pituitary. Chlorpromazine acts presumably at the hypothalamic level to increase prolactin secretion. L-Dopa (D,L-α-hydrazino-α-methyl-β-[3,4-di-hydroxyphenyl]) has the opposite effect; it inhibits prolactin secretion and may be effective in suppressing galactorrhea.
Click on an image below to see the page. View PDF of the complete article